NutriBand (NTRB) Change in Accured Expenses (2016 - 2026)
NutriBand's (NTRB) quarterly Change in Accured Expenses came in at -$102473.0 in Q1 2026, up 47.0% year-on-year from -$69711.1 in Q1 2025, and up 78.23% quarter-over-quarter from -$470623.0 in Q4 2025.
NutriBand (NTRB) Change in Accured Expenses (2016 - 2026) Analysis & Trends
NutriBand has disclosed Change in Accured Expenses across 11 years of filings, most recently posting -$102473.0 for Q1 2026.
- Change in Accured Expenses for Q1 2026 came in at -$102473.0, up 47.0% year-over-year; the trailing twelve-month figure through Jan 2026 was $120943.0 (up 412.23% YoY), and the FY2026 annual result was $120943.0, up 412.23% from the prior year.
- Change in Accured Expenses came in at -$102473.0 for Q1 2026 at NutriBand, up from -$470623.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $671189.0 in Q3 2025 to a low of -$470623.0 in Q4 2025.
- The 5-year median for Change in Accured Expenses is -$2865.0 (2022), against an average of $13866.0.
- Across the five-year window, Change in Accured Expenses jumped 29851.29% in 2024 and plunged 515.28% in 2025, its largest moves.
- NutriBand's Change in Accured Expenses stood at -$85020.0 in 2022, then retreated by 28.11% to -$108916.0 in 2023, then soared by 204.05% to $113327.0 in 2024, then slumped by 515.28% to -$470623.0 in 2025, then surged by 78.23% to -$102473.0 in 2026.
- The last three Change in Accured Expenses figures came in at -$102473.0 (Q1 2026), -$470623.0 (Q4 2025), and $671189.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 931,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 70.50 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | NutriBand | 41.91 Mn | 37.33 Mn | 88,941.00 | -102,473.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -102,473.00 |
| Jan 31, 2026 | -102,473.00 |
| Oct 31, 2025 | -470,623.00 |
| Oct 31, 2025 | -470,623.00 |
| Jul 31, 2025 | 671,189.00 |
| Jul 31, 2025 | 671,189.00 |
| Apr 30, 2025 | 22,850.00 |
| Apr 30, 2025 | 22,850.00 |
| Jan 31, 2025 | -193,333.00 |
| Jan 31, 2025 | -193,333.00 |
| Oct 31, 2024 | 113,327.00 |
| Oct 31, 2024 | 113,327.00 |
| Jul 31, 2024 | -210,357.00 |
| Jul 31, 2024 | -210,357.00 |
| Apr 30, 2024 | 313,974.00 |
| Apr 30, 2024 | 313,974.00 |
| Jan 31, 2024 | 345,710.00 |
| Jan 31, 2024 | 345,710.00 |
| Oct 31, 2023 | -108,916.00 |
| Oct 31, 2023 | -108,916.00 |